Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
and solving practical issues with senior scientists and administrative colleagues in Cambridge and GSK. You will be based in Cambridge, with possible occasional travel within the UK. You will be line
-
We have an exciting opportunity for a Postdoctoral Research Scientist to join the newly established multidisciplinary Oxford-GSK Institute for Molecular & Computational Medicine (IMCM) operating
-
The newly established Oxford-GSK Institute of Molecular & Computational Medicine (IMCM), operating within the Nuffield Department of Medicine, is seeking to appoint a Bioinformatician to join the
-
, University of Glasgow, University of Liverpool and University of Manchester) and four industry partners (GSK, AstraZeneca, Optum and Hammersmith Medicines Research) will provide a unique powerfully synergistic
-
neurodegenerative diseases, reporting to the Oxford-GSK IMCM co-director Professor John Todd and Dr Anna Sher, Director in Quantitative Systems Pharmacology at GSK, and with oversight from the Oxford-GSK IMCM
-
View All Vacancies GSK Carbon Neutral Laboratory for Sustainable Chemistry Jubilee Campus at the University of Nottingham NG7 2TU Location: Jubilee Campus Salary: £30,487 to £33,966 per annum, (pro
-
Are you looking for a new and exciting career opportunity? The Oxford-GSK IMCM are seeking a Senior Bioinformatician, to join the team! The initial focus of the IMCM is on neurodegeneration and the
-
at the University of Nottingham associated with the EPSRC funded Prosperity Partnership “Accelerated Discovery and Development of New Medicines”, which is operated in partnership with GSK. This is a fixed term, part
-
at the University of Nottingham associated with the EPSRC funded Prosperity Partnership “Accelerated Discovery and Development of New Medicines”, which is operated in partnership with GSK. This is a fixed term, part
-
Are you looking for a new and exciting career opportunity? The Oxford-GSK IMCM are seeking a Senior Bioinformatician, to join the team! The initial focus of the IMCM is on neurodegeneration and the